Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Sep 21, 2018 in Coronary artery disease | 0 comments

In a nutshell

This study investigated if the use of multivitamin and mineral (MVM) reduces the risk of heart attack in patients with coronary heart disease (CHD). They found that MVM use reduced the risk of death in patients with CHD not taking statins (cholesterol-lowering drugs).

Some background

Coronary heart disease (CHD) is a condition that can lead to serious events such as heart attack, stroke or death. It can be treated using several strategies. Lifestyle changes are very important. Patients should stop smoking, eat a healthy diet and exercise regularly. Medication can also be prescribed. Statins are common medications used for this. Statins reduce the build-up of cholesterol, a fatty substance that causes CHD.

A recent clinical trial showed that taking high-dose multivitamins and minerals (MVM) might reduce the risk of CHD events. In this trial, patients that did not take statins had the greatest benefit from MVM.

Methods & findings

This study included 460 patients with CHD aged over 50. These patients were not taking statins. 224 patients were taking MVM and 236 patients were taking placebo (inactive tablets). The study lasted 55 months on average for each patient. The number of CHD events were recorded. These included heart attack, stroke, and death. 

There was a 38% lower risk of CHD events in patients taking MVM, compared to the placebo group. Patients taking MVM had a 53% reduced risk of death of all causes. MVM patients also had a 54% reduced risk of death related to CHD events (e.g. stroke, heart attack).

The bottom line

The authors concluded that MVM use reduced the risk of death in patients with CHD not taking statins.

The fine print

This was a relatively small study. Another larger study testing MVM is needed to see if there are any real benefits. The dose of MVM was high and the safety of this needs further investigation.

What’s next?

If you have any concerns regarding coronary heart disease treatment please discuss with your physician.

Published By :

American heart journal

Date :

Jan 01, 2018

Original Title :

Effect of high-dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT).

click here to get personalized updates